A nonsignificant trend towards worse outcomes for cases with combined pathology ( N = 133, P -value ADNC = .56), high CERAD ( P -value CERAD = .33) score and advanced Braak & Braak stage ( P -value Braak & Braak = .11, Figure 4I– K ) was observed.
← all excerpts
Frequent Alzheimer's disease neuropathological change in patients with glioblastoma.
1
—
—